{"id":3354,"date":"2019-01-03T08:26:11","date_gmt":"2019-01-03T16:26:11","guid":{"rendered":"http:\/\/depts.washington.edu\/diabetes\/?p=3354"},"modified":"2019-01-03T08:26:11","modified_gmt":"2019-01-03T16:26:11","slug":"http-r-smartbrief-com-resp-levycehuifdgntptciegiwcicnfanbformatmultipart","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/http-r-smartbrief-com-resp-levycehuifdgntptciegiwcicnfanbformatmultipart\/","title":{"rendered":"Study finds no link between canagliflozin, fracture risk in diabetes"},"content":{"rendered":"<section class=\"kc-elm kc-css-328844 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-227840 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-252102 kc_text_block\">\n<p>Researchers used a cohort of 159,928 patients with type 2 diabetes, mean age of 55, and found that both canagliflozin and GLP-1 receptor agonist users had similar event rates for forearm, hip, humerus or pelvis fracture requiring intervention, with an overall hazard ratio of 0.98. The findings in the <a class=\"\" href=\"http:\/\/r.smartbrief.com\/resp\/levyCehuiFDgnTpWCieGiwCicNMuYR\" target=\"_blank\" rel=\"noopener\">Annals of Internal Medicine<\/a> revealed that users of the drugs also had a similar risk for ankle, carpal, hip, humerus, metacarpal, metatarsal, pelvic, radius or ulna fracture.<\/p>\n<p><span class=\"mobile_wrap\"><a class=\"\" href=\"http:\/\/r.smartbrief.com\/resp\/levyCehuiFDgnTpTCieGiwCicNFaNb?format=multipart\" target=\"_blank\" rel=\"noopener\">Physician&#8217;s Briefing\/HealthDay News<\/a><span class=\"\"> (1\/2)<\/span><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3354","post","type-post","status-publish","format-link","hentry","category-diabetes-related-news","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/3354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=3354"}],"version-history":[{"count":2,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/3354\/revisions"}],"predecessor-version":[{"id":3540,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/3354\/revisions\/3540"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=3354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=3354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=3354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}